Advertisement
YOU ARE HERE: LAT HomeCollectionsJohnson Johnson Co
IN THE NEWS

Johnson Johnson Co

FEATURED ARTICLES
BUSINESS
February 22, 1992 | From Times Staff and Wire Reports
Excedrin Makers Give Rival a Headache: The makers of Excedrin PM said they have obtained a federal court order against the makers of Tylenol PM for allegedly trying to confuse the public by using packaging similar to their product. The makers of Tylenol PM denied the allegation and plan to appeal the decision. Bristol-Meyers Squibb Co. filed a suit last May, contending that McNeil-PCC Inc. violated federal trademark laws. Judge Arthur D. Spatt of the U.S.
ARTICLES BY DATE
BUSINESS
April 4, 1998 | Bloomberg News
Johnson & Johnson Co.'s LifeScan plant in Milpitas, Calif., was searched by investigators for the Justice Department and the Food and Drug Administration for evidence of possible criminal violations, the company and a law enforcement official said. The U.S.
Advertisement
BUSINESS
April 4, 1998 | Bloomberg News
Johnson & Johnson Co.'s LifeScan plant in Milpitas, Calif., was searched by investigators for the Justice Department and the Food and Drug Administration for evidence of possible criminal violations, the company and a law enforcement official said. The U.S.
BUSINESS
February 22, 1992 | From Times Staff and Wire Reports
Excedrin Makers Give Rival a Headache: The makers of Excedrin PM said they have obtained a federal court order against the makers of Tylenol PM for allegedly trying to confuse the public by using packaging similar to their product. The makers of Tylenol PM denied the allegation and plan to appeal the decision. Bristol-Meyers Squibb Co. filed a suit last May, contending that McNeil-PCC Inc. violated federal trademark laws. Judge Arthur D. Spatt of the U.S.
NEWS
July 19, 1985 | United Press International
Some containers of children's Tylenol Elixir have been recalled from wholesalers because they contain common yeast or mold, a spokesman for Johnson & Johnson Co. of New Brunswick said Thursday. None of the contaminated product was sold to consumers.
NEWS
June 19, 1990
Evangeline Johnson Merrill, 93, a patron of the arts and the last surviving child of Johnson & Johnson co-founder Robert Wood Johnson. She served with the Red Cross during World War I and was decorated by President Woodrow Wilson, fought the city of Palm Beach, Fla., over a 1920s ban on women's abbreviated bathing suits and in 1938 married conductor Leopold Stokowski. (To protest the bathing suit ban, she had dropped handbills from a small plane she had just learned to fly.) Mrs.
BUSINESS
August 6, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
Luther Medical Products Inc. said Wednesday that royalties from Johnson & Johnson Co. for its stickless catheter may be in jeopardy after the New Jersey-based medical products giant signed a licensing agreement with another company to produce a stickless needle. Although no royalties to Luther Medical have been withheld, Luther Medical President W. Tate Scott said that his company was informed by Johnson & Johnson that a new agreement with British Technology Group Ltd.
NEWS
April 16, 1986 | From Times Wire Services
Two composite sketches and a tape recording of "Gary," the man suspected in the recent poison contamination of Contac, Teldrin and Dietac capsules, were released Tuesday by the FBI. "This individual's actions are considered to represent a grave danger to society, and the FBI continues a very intensive investigation to identify and apprehend him," said W. Douglas Gow, special agent in charge of the Houston FBI office.
NEWS
November 10, 1988 | From Times Wire Services
Never underestimate the wealth of a New York woman. About two dozen of them can claim a net worth of at least $100 million, and dozens more are worth tens of millions each. Manhattan men make headlines with paper fortunes and power games, but an article in Town & Country said Manhattan women own huge and enduring fortunes of their own. "Women don't exaggerate the way men do," said Julien Studley, head of a Manhattan commercial real estate company.
BUSINESS
February 8, 1990 | LINDA WILLIAMS, TIMES STAFF WRITER
The regents of the University of California on Wednesday sued Eli Lilly & Co., alleging that the largest U.S. maker of insulin infringed on a university patent for the biotechnology that Lilly uses to make its genetically engineered insulin product. The university obtained the patent in 1984 after the technology was developed by four scientists at UC San Francisco, the regents said in a complaint filed in U.S. District Court in San Francisco.
Los Angeles Times Articles
|